Sign inJoin free

Watch / Global Markets

Why global pharma is worth a look

19 Aug 20216:00

Why global pharma is worth a look

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Positive earnings and a revaluation have helped the US pharma sector outperform in recent weeks. Alastair MacLeod from Wheelhouse Partners has been flagging for a while that the sector is incredibly cheap, and a good inflation hedge to boot. We speak with him about the drivers and how the vaccine rollout and profit vs not-for-profit will potentially impact performance going forward. Interestingly, Alastair examines big pharma through an ESG lens as well. Australian investors take note, if you want to gain exposure to big profits from big pharma, Alistair says you'll have to look overseas.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy